“…Nine healthy control subjects (9 male, mean age±SE was 22±1 yr, mean weight 78±3 kg, mean BMI 23.4±1.0 kg/M2) and six C-peptide negative type I diabetic subjects (4 male, 2 female, mean age 34±2 yr, mean weight 73±3 kg, mean BMI 23.5±2.4 kg/m2, mean duration of diabetes 16±4 yr) were studied. All of the IDDM subjects were on an insulin regimen consisting of a subcutaneous injection of regular insulin (2-14 units, Humulin R; Lilly, Indianapolis, IN) administered 20-30 min before each meal and a subcutaneous injection of intermediate (8)(9)(10)(11)(12) units, Humulin NPH; Lilly) or long acting units, Humulin Ultralente; Lilly) insulin given at bedtime, with the exception of two IDDM subjects who also had a subcutaneous injection of intermediate (8)(9)(10)(11)(12) units, Humulin NPH; Lilly) in the morning in addition to their bedtime dose of NPH insulin. None of the IDDM subjects had any renal complications from diabetes and all were in fair and stable control (mean glycosylated hemoglobin was 10.2±0.3%, normal range 4-8%) for .…”